Blend Labs (NYSE: BLND) accounting chief sells under preset plan

Rhea-AI Filing Summary

Blend Labs, Inc. (BLND) reported that Oxana Tkach, its Principal Accounting Officer, sold 21,209 shares of Class A Common Stock on August 17, 2026, in a transaction reported as a sale in the open market or a private transaction under a Rule 10b5-1 trading plan adopted on May 15, 2026. The weighted average sale price was $1.4468 per share, with individual sale prices ranging from $1.44 to $1.465 per share. After this transaction, Tkach directly held 96,238 shares of Blend Labs Class A Common Stock.

Insider Trade Summary 10b5-1

Net Seller: 21,209 shares

Net Sell 1 txn

Insider Tkach Oxana

Role PRINCIPAL ACCOUNTING OFFICER

Sold 21,209 shs ($31K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock F1, F2	21,209	$1.4468	$31K

Holdings After Transaction: Class A Common Stock — 96,238 shares (Direct)

Footnotes (2)

1. F1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 15, 2026.
2. F2. This sale price represents the weighted average sale price of the shares sold ranging from $1.44 to $1.465 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Key Figures

Shares sold: 21,209 shares Weighted average sale price: $1.4468 per share Sale price range: $1.44 to $1.465 per share +3 more

6 metrics

Shares sold 21,209 shares Class A Common Stock sold by Oxana Tkach on August 17, 2026

Weighted average sale price $1.4468 per share Average price for 21,209 shares sold on August 17, 2026

Sale price range $1.44 to $1.465 per share Range of prices for shares included in the reported sale

Shares held after transaction 96,238 shares Direct Class A Common Stock holdings of Oxana Tkach after the sale

10b5-1 plan adoption date May 15, 2026 Adoption date of the Rule 10b5-1 trading plan used for this sale

Transaction date August 17, 2026 Date of the reported sale transaction

Key Terms

Rule 10b5-1 trading plan, weighted average sale price, Class A Common Stock

3 terms

Rule 10b5-1 trading plan regulatory

"sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average sale price financial

"This sale price represents the weighted average sale price of the shares sold"

Class A Common Stock financial

"security title: Class A Common Stock"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

FAQ

What insider transaction did BLND report for Oxana Tkach on August 17, 2026?

Blend Labs (BLND) reported that Oxana Tkach sold 21,209 shares of Class A Common Stock on August 17, 2026. The transaction was reported as a sale in the open market or a private transaction under a Rule 10b5-1 trading plan.

At what price did Oxana Tkach sell Blend Labs (BLND) shares?

Oxana Tkach sold the shares at a weighted average price of $1.4468 per share. Individual sale prices ranged from $1.44 to $1.465 per share, with full per-trade details available upon request from the company or regulator.

How many Blend Labs (BLND) shares does Oxana Tkach hold after this sale?

After the August 17, 2026 sale, Oxana Tkach directly holds 96,238 shares of Blend Labs Class A Common Stock. This post-transaction holding reflects only the shares reported in this Form 4 and may not include other unreported positions.

Was the August 17, 2026 BLND insider sale by Oxana Tkach under a Rule 10b5-1 plan?

Yes. The filing states the sale was effected under a Rule 10b5-1 trading plan adopted by Oxana Tkach on May 15, 2026. Such plans pre-schedule trades, which can reduce the timing significance of the transaction.

Who is the insider involved in the latest BLND Form 4 transaction?

The insider is Oxana Tkach, who serves as Principal Accounting Officer of Blend Labs, Inc. She reported selling 21,209 shares of Class A Common Stock on August 17, 2026, and holding 96,238 shares afterward.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/19/2026 - 04:05 PM Accepted by SEC EDGAR 08/19/2026 - 04:05 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tkach Oxana

(Last) (First) (Middle)

7250 REDWOOD BLVD., SUITE 300

(Street)

NOVATO CALIFORNIA 94945

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Blend Labs, Inc. [ BLND ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	PRINCIPAL ACCOUNTING OFFICER

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/17/2026		S(1)		21,209	D	$1.4468(2)	96,238	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 15, 2026.

2. This sale price represents the weighted average sale price of the shares sold ranging from $1.44 to $1.465 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

	/s/ Kostian Ciko, Attorney-in-fact	08/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)